For the quarter ending 2026-03-31, XMTR had $6,050K increase in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Segment revenue | 205,138 | 192,397 | 180,716 | 162,547 |
| Segment cost of revenue | 126,650 | 117,160 | 108,687 | 97,371 |
| Segment adjusted operating expense | 68,180 | 67,041 | 66,071 | 61,434 |
| US | -177 | -186 | -184 | -184 |
| Non Us | 0 | - | 0 | 0 |
| Other segment items | -177 | -186 | -184 | -184 |
| Total adjusted ebitda | 10,485 | 8,382 | 6,142 | 3,926 |
| Interest expense, interest and dividend income and other expenses | -63 | -892 | 775 | 16,343 |
| Depreciation and amortization | 4,931 | 5,009 | 5,000 | 4,495 |
| Amortization of lease intangible | 0 | 180 | 180 | 180 |
| Provision for income taxes | 248 | 614 | -17 | -8 |
| Stock-based compensation | 8,327 | 10,377 | 10,748 | 7,895 |
| Payroll tax expense related to stock-based compensation | 1,605 | 365 | 366 | 261 |
| Acquisition and other | 0 | 237 | 0 | 676 |
| Charitable contribution of common stock | 826 | 1,192 | 950 | 614 |
| Income from unconsolidated joint venture | 146 | -140 | 220 | 218 |
| Impairment of assets | - | 0 | 49 | - |
| Restructuring charges | 16 | -202 | -92 | 95 |
| Net loss | -5,259 | -8,638 | -11,597 | -26,437 |
| Depreciation and amortization | 4,931 | 5,009 | 5,000 | 4,495 |
| Impairment of assets | - | 0 | 49 | - |
| Reduction in carrying amount of right-of-use asset | 552 | 1,288 | 1,138 | 1,112 |
| Lease termination | 0 | 0 | -16 | 0 |
| Stock-based compensation | 8,327 | 10,377 | 10,748 | 7,895 |
| Revaluation of contingent consideration | - | 0 | 0 | 0 |
| Income from unconsolidated joint venture | 86 | -54 | 54 | 0 |
| Donation of common stock | 826 | 1,192 | 950 | 614 |
| Loss on debt extinguishment | - | 0 | 0 | -16,430 |
| Loss on sale of property and equipment | - | 0 | 0 | 0 |
| Inventory write-off | - | 0 | - | - |
| Amortization of deferred costs on convertible notes | 571 | 571 | 590 | 472 |
| Deferred tax benefit | - | -40 | -21 | -23 |
| Accounts receivable, net | 22,664 | -1,561 | 9,865 | 147 |
| Inventory | -273 | -327 | -380 | 531 |
| Prepaid expenses | -214 | 1,352 | 786 | -1,401 |
| Other assets | 3,113 | -461 | 1,174 | -1,936 |
| Accounts payable and accrued cost of revenue | 17,657 | -1,568 | 4,367 | -8,687 |
| Other accrued expenses | 11,014 | -1,660 | 7,106 | 2,534 |
| Contract liabilities | 1,761 | -1,019 | 1,120 | 173 |
| Lease liabilities | -340 | -1,690 | -2,032 | -1,639 |
| Other liabilities | -55 | 0 | -2 | -9 |
| Income taxes payable | 14 | -461 | -141 | -16 |
| Net cash provided by (used in) operating activities | 14,623 | 4,412 | 5,792 | -427 |
| Purchases of marketable securities | 12,280 | 1,971 | 2,133 | 2,167 |
| Proceeds from sale of marketable securities | 13,500 | 1,500 | 7,500 | 9,000 |
| Purchases of property and equipment | - | 10,269 | 7,449 | 6,963 |
| Capitalization of software development and purchases of property and equipment | 10,581 | - | - | - |
| Distributions in excess of earnings | 40 | 20 | - | -18 |
| Proceeds from sale of property and equipment | - | 0 | 0 | 0 |
| Cash paid for business combination, net of cash acquired | - | 0 | - | - |
| Net cash used in investing activities | -9,321 | -10,654 | -2,148 | -148 |
| Proceeds from issuance of convertible notes | - | 0 | 0 | 250,000 |
| Costs incurred in connection with issuance of convertible notes | - | 0 | 828 | 7,822 |
| Payments for repurchase of convertible notes | - | 0 | 0 | 215,992 |
| Purchase of capped calls | - | 0 | 0 | 17,475 |
| Purchase of treasury stock | - | 0 | 0 | 8,080 |
| Proceeds from stock options exercised | 830 | 384 | 1,288 | 905 |
| Payment of contingent consideration | - | 0 | - | - |
| Net cash provided by financing activities | 830 | 384 | 460 | 1,536 |
| Effect of foreign currency translation on cash and cash equivalents | -82 | 9 | -10 | 283 |
| Net increase (decrease) in cash and cash equivalents | 6,050 | -5,849 | 4,094 | 1,244 |
| Cash and cash equivalents at beginning of the period | 14,996 | 20,845 | 16,751 | 15,507 |
| Cash and cash equivalents at end of the period | 21,046 | 14,996 | 20,845 | 16,751 |
Xometry, Inc. (XMTR)
Xometry, Inc. (XMTR)